Advanced Drug Delivery Systems: Technologies and Global Markets
October 25, 2011
Wellesley, Mass. – In a recent release, ADVANCED DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS (PHM006H) from BCC Research (www.bccresearch.com), the global market for advanced drug delivery systems is estimated to reach nearly $137.9 billion in 2011 and $175.6 billion by 2016 at a compound annual growth rate (CAGR) of 5%.
The global market for advanced drug delivery systems can be broken down into three regions – the U.S., Europe, and the rest of the world.
The U.S. region accounted for $81.6 billion in 2011 and in 2016 should be worth $102.6 billion, a CAGR of 4.7%.
The European region, worth nearly $37.5 billion in 2011, should be worth $49.1 billion in 2016, a CAGR of 5.6%.
The rest of the world accounted for nearly $18.8 billion in 2011 and in 2016 should be worth nearly $23.8 billion, a CAGR of 4.8%.
Healthcare costs are causing a need for alternative drug delivery technologies. The drug delivery industry has emerged from the shadow of the pharmaceutical industry and has become an influential factor for pharmaceutical market growth. Drug delivery technologies are considered significant drivers of the global pharmaceutical and biopharmaceutical industry. Because pharmaceutical and biopharmaceutical companies have recognized the strategic advantage of drug delivery technologies, they are applying these advantages to their existing products to protect them from market erosion by generic versions.
The drug delivery market is a well-established and important sector of the pharmaceutical industry. The market is evolving at a rapid rate with continuous research efforts in which numerous drug delivery systems are being developed to improve many of the pharmacological properties of existing conventional drugs.
This study contributes to the areas of market growth in drug delivery systems from the point of view of manufacturers and the users, and, as such, this report will be of interest largely to the pharmaceutical and biopharmaceutical industries, as well as clinics, hospitals, and research institutes.
Advanced Drug Delivery Systems: Technologies and Global Markets( PHM006H )
Publish Date: Oct 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
Reports from Pharmaceuticals
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand